AlphaQuest LLC Takes Position in Henry Schein, Inc. $HSIC

Key Points

• AlphaQuest LLC recently acquired a new stake in Henry Schein, Inc., purchasing 15,597 shares valued at approximately $1,068,000 in the first quarter.
• Multiple hedge funds have increased their positions in Henry Schein, contributing to an institutional ownership rate of 96.62% of the company's stock.
• Henry Schein reported earnings per share (EPS) of $1.10 for the last quarter, missing analysts' expectations, while the company's revenue was up 3.3% compared to the previous year.

AlphaQuest LLC acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 15,597 shares of the company's stock, valued at approximately $1,068,000.

Other hedge funds also recently modified their holdings of the company. Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 237.3% in the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock valued at $186,000 after acquiring an additional 1,898 shares in the last quarter. State of Alaska Department of Revenue grew its position in Henry Schein by 2.8% in the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock valued at $1,000,000 after purchasing an additional 395 shares during the period. Oppenheimer Asset Management Inc. grew its position in Henry Schein by 5.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after purchasing an additional 678 shares during the period. GAMMA Investing LLC grew its position in Henry Schein by 37.8% in the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after purchasing an additional 1,081 shares during the period. Finally, Cetera Investment Advisers grew its position in Henry Schein by 14.7% in the 1st quarter. Cetera Investment Advisers now owns 4,924 shares of the company's stock valued at $337,000 after purchasing an additional 630 shares during the period. Institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

HSIC has been the subject of several research reports. Robert W. Baird reissued a "neutral" rating and issued a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Barrington Research reduced their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday, August 6th. Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Baird R W downgraded shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Finally, Evercore ISI reduced their price target on shares of Henry Schein from $78.00 to $70.00 and set an "in-line" rating for the company in a research report on Wednesday, August 6th. Four analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, Henry Schein currently has a consensus rating of "Hold" and a consensus target price of $75.58.

Henry Schein Price Performance

HSIC opened at $69.60 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The company has a market capitalization of $8.44 billion, a price-to-earnings ratio of 22.45, a P/E/G ratio of 2.30 and a beta of 0.81. The firm's fifty day moving average price is $70.55 and its two-hundred day moving average price is $70.37. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.Henry Schein's revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.